Pacific Heart, Lung & Blood Institute to Hold Mesothelioma Fundraiser
The Pacific Heart, Lung & Blood Institute in California will hold its third annual mesothelioma fundraiser in October to raise money for cancer research.
The Pacific Heart, Lung & Blood Institute in California will hold its third annual mesothelioma fundraiser in October to raise money for cancer research.
Researchers at Georgia Regents University Cancer Center are accepting mesothelioma patients who want to participate in an immunotherapy clinical trial.
Researchers found that repeating the debulking and HIPEC procedure in some peritoneal mesothelioma patients two or three times can extend survival.
Leading international cancer doctors and researchers are evaluating a proposed staging system for patients diagnosed with peritoneal mesothelioma.
Researchers at the Perelman School of Medicine are using a dye and near-infrared light to make cancer cells glow to reduce cancer recurrence.
A clinical trial at the Ohio State University Comprehensive Cancer Center will use photodynamic therapy to kill cancer cells in mesothelioma patients.
A 2014 Creighton University Medical Center study shows that chemotherapy drug carboplatin is the best option for peritoneal mesothelioma undergoing a HIPEC procedure.
Researchers at the National Institutes of Health will be testing an immunotherapy vaccine on patients to see if it will prevent or delay cancer recurrence.
Researchers say new study shows early palliative care lessens hospital stays and deaths, and improves cancer patients’ physical and mental well-being.
It is never too early for a patient diagnosed with mesothelioma — or most any cancer — to start consulting with a palliative care specialist, according to a recent study.
The message from researchers at the University of Texas MD Anderson Cancer Ce…
Researchers in the U.K. developed a new blood test that detects cancer after exposing a person’s white blood cells to UV light.
Japanese researchers developed a simple blood test that could more accurately diagnose mesothelioma, leading to earlier cancer treatment.
Armed with a new $8 million grant, researchers at Penn Medicine hope to prove that photodynamic therapy is highly effective at treating pleural mesothelioma.
The Centers for Disease Control and Prevention reinstated a $2.2 million research grant to continue research at the National Mesothelioma Virtual Bank.
New research shows that people who were exposed to toxic asbestos fibers do not outlive their risk of developing deadly mesothelioma.